Painreform is trading 6.36% down at $1.03 with no confirmed company-specific catalyst identified.

  • Painreform closed at $1.10 on August 11, 2026.
  • Available coverage reports no recent press releases, and no confirmed announcement, earnings release, regulatory action, or analyst event explains the decline.
  • The move appears consistent with a cautious overnight backdrop, including a 0.66% Nasdaq Composite decline and positioning ahead of August 12 CPI data.